Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158923 · ClinicalTrials.gov registry record · NA
Individualized Perioperative Open Lung Ventilatory Strategy
A NA study of Moderated-high Risk of Postoperative Pulmonary Complication and Abdominal Surgery Expected More Than Two Hours, sponsored by Fundación para la Investigación del Hospital Clínico de Valencia.
- Completed
- Registry status
- NA
- Development phase
- 920
- Enrollment target
- 7
- Study locations
NCT02158923: Completed NA study of Moderated-high Risk of Postoperative Pulmonary Complication and Abdominal Surgery Expected More Than Two Hours, sponsored by Fundación para la Investigación del Hospital Clínico de Valencia.
NCT02158923 is a NA study of Moderated-high Risk of Postoperative Pulmonary Complication and Abdominal Surgery Expected More Than Two Hours that has completed, run by Fundación para la Investigación del Hospital Clínico de Valencia. The registered enrollment target is 920 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02158923, a NA study of Moderated-high Risk of Postoperative Pulmonary Complication and Abdominal Surgery Expected More Than Two Hours, has completed, sponsored by Fundación para la Investigación del Hospital Clínico de Valencia.
- COMPLETED
- Registry status
- NA
- Development phase
- 920 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to determine whether individualized ventilatory management combining the use of low tidal volumes, alveolar recruitment maneuvers, individually titrated positive end-expiratory pressure and postoperative individualized ventilatory support will decrease postoperative complications, unplanned ICU readmissions, ICU and hospital length of stay and mortality compared to a standardized Lung Protective Ventilation (LPV) for all patients at risk.
Conditions Studied
Interventions
- PROCEDURE Alveolar recruitment maneuver
- PROCEDURE Calculation of optimal PEEP
- PROCEDURE Postoperative CPAP
Study Locations (7)
Barcelona
- Hospital Germans Trias i Pujol - Badalona
- Hospital de la Santa Creu i Sant Pau - Barcelona
Massachusetts
- Massachusetts General Hospital - Boston
Buenos Aires
- Hospital Privado de la Comunidad - Mar del Plata
Madrid
- Hospital Gregorio Marañón - Madrid
Valencia
- Department of Anesthesia and Critical Care; Hospital Clinico Universitario - Valencia
Uppland
- Uppsala University Hospital - Uppsala
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 920 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT02158923 record still lists
NCT02158923 is an interventional study that assigns participants to a tested intervention. The registered 920 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).
The record links to 2 conditions, with Moderated-high Risk of Postoperative Pulmonary Complication appearing as the primary indexed condition, and to 3 interventions - of which Alveolar recruitment maneuver is the first listed.
NCT02158923 lists 7 locations in 6 states (Barcelona, Massachusetts, Buenos Aires).
Frequently Asked Questions
What is clinical trial NCT02158923 about?
NCT02158923 is a clinical study titled "Individualized Perioperative Open Lung Ventilatory Strategy". The purpose of this study is to determine whether individualized ventilatory management combining the use of low tidal volumes, alveolar recruitment maneuvers, individually titrated positive end-expiratory pressure and postoperative individualized ventilatory support will decrease postoperative comp...
What is the current status of trial NCT02158923?
This trial is currently completed. It is a NA study. The enrollment target is 920 participants. The study started on 2014-09. Estimated completion is 2016-04.
What conditions does trial NCT02158923 study?
This clinical trial studies the following conditions: Moderated-high Risk of Postoperative Pulmonary Complication, Abdominal Surgery Expected More Than Two Hours.
What interventions are being tested in trial NCT02158923?
The interventions under investigation include: Alveolar recruitment maneuver (PROCEDURE), Calculation of optimal PEEP (PROCEDURE), Postoperative CPAP (PROCEDURE).
Who is sponsoring clinical trial NCT02158923?
This trial is sponsored by Fundación para la Investigación del Hospital Clínico de Valencia, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02158923 being conducted?
This trial has 7 study locations across Massachusetts, Buenos Aires, Barcelona, Madrid, Valencia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02158923's enrollment target sits among peer trials
920 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- NCT07174336 · 920 participants · Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia